IUHSA
IOVA icon

Itau Unibanco Holding S.A.’s Iovance Biotherapeutics IOVA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,915
Closed -$15.4K – 377
2024
Q2 		$15.4K Buy
+1,915
New +$20.5K ﹤0.01% 249
2022
Q4 		– Sell
-221
Closed -$2K – 570
2022
Q3 		$2K Hold
221
– – ﹤0.01% 527
2022
Q2 		$2K Buy
+221
New +$2.9K ﹤0.01% 451

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Itau Unibanco Holding S.A.'s IOVA Position: Q3 2024 in Review

Itau Unibanco Holding S.A. sold out of Iovance Biotherapeutics (IOVA) in Q3 2024, closing a stake of 1,915 shares — an estimated $15.4K sold.

Itau Unibanco Holding S.A. first reported a position in IOVA in Q2 2022 and held it in 3 quarters. The position peaked at $15.4K in Q2 2024. 286 funds tracked by Wall St. Rank hold IOVA as of Q3 2024.

  • Itau Unibanco Holding S.A. reported no remaining Iovance Biotherapeutics position as of Q3 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 1,915 Iovance Biotherapeutics shares in Q3 2024, an estimated $15.4K.
  • Itau Unibanco Holding S.A. first reported a position in Iovance Biotherapeutics in Q2 2022 and held it in 3 quarters.
  • Itau Unibanco Holding S.A.'s Iovance Biotherapeutics position peaked at $15.4K in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2024, filed 14 Nov 2024.